Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission from purchases made through links on this page.

(Bloomberg) — The World Health Organization added Novo Nordisk A/S’s Ozempic and Eli Lilly & Co.’s Mounjaro to its list of essential medicines, a step that may expand access to the drugs around the world.

The recommendation applies to a range of GLP-1 drugs that also includes Lilly’s older medicine Trulicity and Novo’s Victoza, the WHO said on Friday.

The public health agency didn’t say it’s essential to take GLP-1s for obesity as a standalone condition, instead focusing on their use for diabetes patients who also have heart or kidney disease as well as obesity. That’s because the strongest evidence that the drugs he

See Full Page